Teladoc Health, Inc. · BMV:TDOC

Teladoc Health, Inc. financial statements

Teladoc Health, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.53B2.57B2.60B2.41B2.03B1.09B553.3M417.9M233.3M123.2M
Cost of revenue744.0M650.3M390.8M184.5M128.7M61.6M32.0M
Gross profit1.66B1.38B703.1M368.8M289.2M171.7M91.2M
Research and development277.9M307.3M348.5M333.6M311.9M164.9M64.6M54.4M34.5M21.8M
Operating income-263.0M-1.02B-248.6M-13.7B-265.6M-506.4M-80.4M-70.9M-75.4M-62.7M
Depreciation and amortization256.0M204.2M69.5M39.0M35.6M19.1M8.27M
EBITDA-13.4B-61.4M-436.9M-41.5M-35.3M-56.3M-54.4M
Interest expense19.7M23.8M22.3M21.9M81.1M
Income before tax-235.5M-993.7M-219.6M-13.7B-384.7M-576.0M-109.5M-97.0M-107.0M-73.7M
Income tax-35.2M7.59M760.0K-3.81M44.1M-90.9M-10.6M118.0K-225.0K510.0K
Net income-200.3M-1.00B-220.4M-13.7B-428.8M-485.1M-98.9M-97.1M-106.8M-74.2M
Earnings per share, basic-1.14-5.87-1.34-84.60-2.73-5.36-1.38-1.47-1.93-1.75
Earnings per share, diluted-1.14-5.87-1.34-84.60-2.73-5.36-1.38-1.47-1.93-1.75

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents781.1M1.30B1.12B918.2M893.5M733.3M514.4M424.0M42.8M50.0M
Short-term investments02.54M53.2M2.71M54.5M
Receivables192.8M214.1M217.4M210.6M169.0M169.3M56.9M43.6M27.1M13.8M
Inventory38.2M38.1M29.5M56.3M73.1M56.5M0
Current assets1.12B1.66B1.49B1.32B1.23B1.06B588.0M532.7M156.2M82.7M
Property, plant and equipment27.0M29.5M32.0M29.6M27.2M28.6M10.3M10.1M8.96M7.48M
Goodwill283.2M283.2M1.07B1.07B14.5B14.6B746.1M737.2M498.5M188.2M
Total assets2.86B3.52B4.39B4.35B17.7B17.8B1.60B1.53B824.4M303.7M
Accounts payable48.0M33.1M43.6M47.7M47.3M46.0M9.07M7.77M3.88M2.24M
Current liabilities404.7M941.5M420.6M399.8M331.0M332.6M90.2M62.4M40.3M21.1M
Long-term debt42.4M
Total debt042.6M044.4M
Total liabilities1.47B2.03B2.07B
Shareholders' equity1.39B1.49B2.33B2.31B16.0B15.9B1.01B1.01B558.9M230.9M
Shares outstanding178.3M173.4M166.7M162.8M160.5M150.3M72.8M70.5M61.5M46.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations294.4M293.7M350.0M189.3M194.0M-53.5M29.9M-4.86M-34.4M-51.9M
Capital spending-8.89M-10.8M-11.5M-16.5M-8.53M-4.02M-3.51M-4.01M-2.63M-2.11M
Free cash flow285.5M282.9M338.6M172.8M185.5M-57.5M26.4M-8.87M-37.1M-54.0M
Cash from investing-266.0M-124.1M-156.3M-167.7M-73.0M-591.0M25.0M-257.5M-448.4M26.1M
Cash from financing-551.7M8.31M10.9M6.50M40.9M859.1M35.1M645.6M475.4M20.7M
Change in cash-523.3M177.9M204.5M28.0M162.0M214.7M90.0M383.3M-7.39M